Mednet Logo
SpecialtiesHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

What is your approach to secondary stroke prevention in patients with atrial fibrillation and intracranial stenosis (>70%)?

9
6 Answers

Mednet Member
Mednet Member
Neurology · Harvard Medical School

The patient clearly needs to be on an anticoagulant for stroke prevention with atrial fibrillation and I would choose apixaban. If an antiplatelet is added to the apixaban, the risk of a major bleeding side effect is significantly increased. It is uncertain if apixaban is effective in reducing the r...

At what lab values (ferritin, TSAT%) would you offer IV iron therapy to patients with restless leg syndrome?

3
2 Answers

Mednet Member
Mednet Member
Hematology · Georgetown University School of Medicine

1. I am hopeful that practitioners will start understanding that ferritin alone is not enough to assess iron because of its acute phase reactivity. I like to order iron parameters after a 5-9 hour fast so the serum iron is not speciously elevated and get a ferritin and TSAT. If the ferritin is <30 a...

How do you utilize Diamox in patients with cerebral venous sinus thrombosis and vision symptoms who do not undergo thrombectomy/recanalization?

3
3 Answers

Mednet Member
Mednet Member
Neurology · The University of Iowa

Diamox (acetazolamide) is often used to treat papilledema with associated visual loss in cases of CVST. While there is a theoretical risk of dehydration from acetazolamide with potential worsening of the thrombosis, 1) acetazolamide is a weak diuretic and 2) the risk of blinding visual loss usually ...

What additional workup would you perform to evaluate a new onset of spontaneous hemarthrosis?

1
1 Answers

Mednet Member
Mednet Member
Hematology · University of Rochester School of Medicine and Dentistry

The workup that you've outlined is essentially complete. Would rule out any possible medication/supplement effects, Would consider the possibility of a vascular fragility syndrome (EDS) or other connective tissue disease, Would rule out vitamin C deficiency, If there is other bleeding that clinical...

Do you still consider propranolol first-line for sinus tachycardia in thyroid storm, or have newer perspectives on beta-blocker risks altered your management?

1 Answers

Mednet Member
Mednet Member
Pulmonology · Northwell Health Physician Partners Pulmonary And Sleep Medicine At Lake Success

Yes, but...Propranolol remains the first-line option for thyroid storm, but recent evidence supports that beta-1 selective agents (metoprolol, atenolol) are equally effective and may be preferred in certain clinical contexts. The choice between propranolol and cardioselective beta-blockers should be...

Do you still consider propranolol first-line for sinus tachycardia in thyroid storm, or have newer perspectives on beta-blocker risks altered your management?

1 Answers

Mednet Member
Mednet Member
Pulmonology · Northwell Health Physician Partners Pulmonary And Sleep Medicine At Lake Success

Yes, but...Propranolol remains the first-line option for thyroid storm, but recent evidence supports that beta-1 selective agents (metoprolol, atenolol) are equally effective and may be preferred in certain clinical contexts. The choice between propranolol and cardioselective beta-blockers should be...

How do you manage/treat acute radiation-induced enteritis?

1
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of North Carolina at Chapel Hill

I have no problem with the excellent comments already made. However, I think it is important to add some comments. First - one needs to be sure that the patient truly has radiation enteritis. Many patients receiving abdominal radiation therapy have other issues that need to be explored first. For ex...

For a patient with acute stroke who cannot tolerate statins, what is your preferred second-line agent for secondary prevention?

1
1 Answers

Mednet Member
Mednet Member
Hospital Medicine · Northwestern Memorial Hospital

First question - is the patient experiencing the nocebo effect? I would explore statin-based symptoms. Ezetimibe - if only needs a small reduction. If you need to be more aggressive, I would use PCSK9 inhibitors. If the patient cannot tolerate a PCSK9 inhibitor or if you need more lowering, you can ...

How do you approach the use and interpretation of the FDA-approved plasma pTau181 blood test for Alzheimer's disease in a community-dwelling older adult with subjective cognitive complaints and a normal cognitive screen?

1
1 Answers

Mednet Member
Mednet Member
Geriatric Medicine · UCLA Medical Center

I follow current guidelines, which recommend against testing in those without objective cognitive impairment, given the high rate of false positives. Unless the pre-test probability is high, I would not test. That having been said, future developments (such as subQ modes of anti-amyloid Rx, greater ...

How long do you treat retroperitoneal fibrosis with immunosuppression?

4
1 Answers

Mednet Member
Mednet Member
Rheumatology · MUSC Health

I normally treat for 9 months to a year depending on response. I have found PET CT useful in determining if there is active ongoing inflammation.